Live from the NIH registry
Studies recruiting near Tulsa right now
Top 25 of 185 recruiting studies, sorted by proximity — each links to its official registry page
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
Tricuspid Regurgitation
N/A
Interventional 65 participants sought
Oklahoma Heart Institute — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laplace Interventional, Inc
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
Depression
Phase 2
Interventional 75 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laureate Institute for Brain Research, Inc.
A Phase 2 Study of NT-101 Topical in Patients With Wet AMD
Wet Age Related Macular Degeneration
Phase 2
Interventional 66 participants sought
Tulsa Retina Consultants — Tulsa, Oklahoma (5.3 mi)
· Sponsor: NexThera Co., Ltd.
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0082) — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Amplification of Positivity for Alcohol Use
Alcohol Use Disorder, Anxiety
N/A
Interventional 100 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laureate Institute for Brain Research, Inc.
Dose-Dependent Effects of Low-Intensity Focused Ultrasound
Healthy Controls
N/A
Interventional 66 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laureate Institute for Brain Research, Inc.
Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression
Treatment-Resistant Depression
N/A
Interventional 140 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laureate Institute for Brain Research, Inc.
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Obesity or Overweight
Phase 3
Interventional 2,500 participants sought
Research Site — Tulsa, Oklahoma (5.3 mi)
· Sponsor: AstraZeneca
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
Normal and Diseased Tissue and Body Fluids Samples
N/A
Observational 100,000 participants sought
St. Jude Affiliate Clinic at Saint Francis Children's Hospital — Tulsa, Oklahoma (5.3 mi)
· Sponsor: St. Jude Children's Research Hospital
Mitigating PTSD-CUD After Sexual Assault
Posttraumatic Stress Disorder, Cannabis Use Disorder
Phase 1, Phase 2
Interventional 68 participants sought
Tulsa Forensic Nursing — Tulsa, Oklahoma (5.3 mi)
· Sponsor: University of Nevada, Las Vegas
Nectero EAST System Clinical Study
Abdominal Aortic Aneurysm
Phase 2, Phase 3
Interventional 400 participants sought
Oklahoma Heart Institute — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Nectero Medical, Inc.
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Mitral Annular Calcification, Mitral Stenosis
N/A
Interventional 210 participants sought
Oklahoma Heart Institute Utica Office — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Mayra Guerrero
The Oklahoma Parent-Child Assistance Program
Substance Use Disorders, Pregnancy Related
N/A
Interventional 200 participants sought
Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: University of Oklahoma
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Oklahoma Cancer Specialists and Research Institute (OCSRI) — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Paradigm Health
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
DelRicht Research - Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Crystalys Therapeutics
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Psoriatic Arthritis, Overweight or Obesity
Phase 4
Interventional 200 participants sought
Essential Medical Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Eli Lilly and Company
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Alopecia Areata
Phase 3
Interventional 674 participants sought
Vital Prospects Clinical Research Institute, PC — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Pfizer
Motiva Implants® Post-Approval Study
Breast Implant
N/A
Interventional 2,400 participants sought
Landis Platic Surgery — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Motiva USA LLC
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Tulsa Retina Consultants — Tulsa, Oklahoma (5.3 mi)
· Sponsor: EyeBiotech Ltd.
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
Stroke, Stroke, Acute
N/A
Observational 1,060 participants sought
Ascension St. John — Tulsa, Oklahoma (5.3 mi)
· Sponsor: University of Cincinnati
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
T-cell Acute Lymphoblastic Leukemia, T-cell Lymphoma
Phase 2
Interventional 100 participants sought
Saint Francis Children's Hospital — Tulsa, Oklahoma (5.3 mi)
· Sponsor: St. Jude Children's Research Hospital
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Phase 4
Interventional 100 participants sought
Oklahoma Cancer Specialists and Research Institute, LLC — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Pfizer
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Axsome Therapeutics, Inc.
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Oklahoma Cancer Specialists and Research Institute-Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: NRG Oncology
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
Breast Cancer, Lymphoma
EARLY/Phase 1
Interventional 104 participants sought
Stephenson Cancer Center- Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: University of Oklahoma